The healthcare provider has ordered 1000 mL of 0.9% sodium chloride to be administered intravenously over 5 hours. The drop factor on the tubing is 15 drops/mL. How many milliliters per hour will you administer and how many drops per minute?

A) "Ventilation is the process of moving air into and out of the lungs."
Ventilation refers to the mechanical process of breathing, which involves the movement of air into and out of the lungs. During ventilation, air containing oxygen is drawn into the lungs through inhalation (inspiration), and carbon dioxide-rich air is expelled from the lungs through exhalation (expiration). This process facilitates the exchange of gases (oxygen and carbon dioxide) between the lungs and the external environment.

B) "Ventilation is taking a breath in."
This statement is too simplistic and does not fully encompass the process of ventilation, which includes both inhalation and exhalation. Ventilation involves not only taking a breath in but also the subsequent process of exhaling.

C) "Ventilation is the blood flow through the lung."
This statement describes perfusion, which is the process of blood flow through the lung's blood vessels, rather than ventilation, which involves air movement in and out of the lungs. Ventilation and perfusion are closely related but distinct processes.

D) "Ventilation is the process by which gases are exchanged."
While ventilation facilitates gas exchange, this statement does not fully capture the mechanical aspect of moving air into and out of the lungs, which is the primary function of ventilation. Gas exchange occurs in the alveoli of the lungs, where oxygen diffuses into the bloodstream, and carbon dioxide diffuses out of the bloodstream, but ventilation refers specifically to the movement of air.

A) Sedation:
Sedation is not an adverse effect commonly associated with oxymetazoline nasal spray. Oxymetazoline works by constricting blood vessels in the nasal passages to relieve congestion and does not typically cause sedation.

B) Constipation:
Constipation is not an adverse effect associated with oxymetazoline nasal spray. Constipation is more commonly associated with medications that affect the gastrointestinal system, such as opioid analgesics or certain anticholinergic medications.

C) Productive cough:
Productive cough is not an adverse effect commonly associated with oxymetazoline nasal spray. Productive cough refers to a cough that produces mucus or phlegm and is more often associated with respiratory infections or chronic respiratory conditions.

D) Nasal congestion.
Oxymetazoline (Afrin) is a nasal decongestant spray commonly used for the temporary relief of nasal congestion associated with allergic rhinitis or the common cold. However, if oxymetazoline nasal spray is used for more than 3 to 5 consecutive days, it can lead to rebound congestion, also known as rhinitis medicamentosa. Rebound congestion occurs when the nasal mucosa becomes dependent on the medication for vasoconstriction, and upon discontinuation, nasal congestion worsens. Therefore, prolonged use of oxymetazoline nasal spray can result in a worsening of nasal congestion as an adverse effect.